Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Chloride,Potassium Carbonate
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Goldman Sachs Asset Management
Deal Size : Undisclosed
Deal Type : Financing
Norgine Announces Closing of Investment from Goldman Sachs Asset Management
Details : The macrogol in Movicol (sodium chloride) binds with water and retains it in the bowel. This allows the water to rehydrate and bulk the stool to trigger renewed colonic activity.
Product Name : Movicol
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
December 15, 2022
Lead Product(s) : Sodium Chloride,Potassium Carbonate
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Goldman Sachs Asset Management
Deal Size : Undisclosed
Deal Type : Financing